| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.9B | $15.3B | $14.7B | $15.7B | $13.7B | $12.2B | $12.6B | $12.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.9B | $2.7B | $3.2B | $2.6B | $2.8B | $2.7B | $2.7B | $2.7B |
| Net Income | $2.0B | $1.8B | $2.5B | $1.7B | $1.3B | $1.1B | $1.3B | $1.4B |
| EPS (Basic) | $5.66 | $5.26 | $7.25 | $4.68 | $3.86 | $3.29 | $4.09 | $4.43 |
| EPS (Diluted) | $5.64 | $5.24 | $7.21 | $4.66 | $3.85 | $3.28 | $4.08 | $4.42 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $74.6B | $70.6B | $66.3B | $69.1B | $63.1B | $62.9B | $58.1B | $53.9B |
| Current Assets | $6.8B | $6.7B | $6.5B | $13.0B | $5.6B | $5.3B | $4.3B | $3.9B |
| Cash & Equivalents | $1.6B | $1.3B | $1.2B | $1.3B | $1.0B | $1.3B | $1.0B | $0.9B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $6.6B | $6.4B | $6.5B | $11.3B | $5.4B | $7.4B | $6.3B | $6.2B |
| Stockholders' Equity | $24.2B | — | $21.2B | $20.7B | $20.0B | $18.8B | $18.0B | $16.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.8B | $3.6B | $2.2B | $3.9B | $2.7B | $2.2B | $3.1B | $2.7B |
| Investing Cash Flow | $-5.2B | $-5.3B | $-1.0B | $-4.6B | $-3.5B | $-4.2B | $-3.8B | $-5.5B |
| Capital Expenditures | — | — | — | $4.5B | $4.0B | $4.1B | $3.7B | $5.2B |
| Financing Cash Flow | $0.7B | $1.8B | $-1.5B | $1.0B | $0.5B | $2.2B | $0.9B | $2.9B |